Biosimilars in clinical practice

被引:1
|
作者
Mikhail, Ashraf [1 ]
机构
[1] Univ Coll Swansea, Morriston Hosp, Renal Unit, Swansea SA6 6NL, W Glam, Wales
来源
关键词
D O I
10.1159/000107096
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
引用
收藏
页码:18 / 22
页数:5
相关论文
共 50 条
  • [1] THE PLACE OF BIOSIMILARS IN CLINICAL PRACTICE
    Taylor, Peter
    RHEUMATOLOGY, 2014, 53 : 6 - 6
  • [2] Rituximab biosimilars in clinical practice
    Jurczak, Wojciech
    Dlugosz-Danecka, Monika
    LEUKEMIA & LYMPHOMA, 2020, 61 (07) : 1523 - 1524
  • [3] Biosimilars: Implications for Clinical Practice
    Rifkin, Robert M.
    Peck, Susan R.
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (09) : 24S - +
  • [4] Fostering the Adoption of Biosimilars Into Clinical Practice
    Terrie, Yvette C.
    US PHARMACIST, 2023, 48 (06) : 36 - 41
  • [5] Insulin biobetters and biosimilars in clinical practice
    Home, Philip
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2023, 53 (02): : 147 - 155
  • [6] Potential problems of biosimilars in clinical practice
    Korucu, Fatma Ceyda
    Nazli, Hakan
    Gedik, Gulsah
    Cicin, Irfan
    MARMARA PHARMACEUTICAL JOURNAL, 2016, 20 (01) : 44 - 51
  • [7] Rituximab biosimilars: introduction into clinical practice
    Makita, Shinichi
    Tobinai, Kensei
    LANCET HAEMATOLOGY, 2017, 4 (08): : E342 - E343
  • [8] Inflammatory diseases: Integrating biosimilars into clinical practice
    Feldman, Steven R.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 44 (06) : S16 - S21
  • [9] Biosimilars in Oncology: From Development to Clinical Practice
    Tkaczuk, Katherine H. Rak
    Jacobs, Ira Allen
    SEMINARS IN ONCOLOGY, 2014, 41 (02) : S3 - S12
  • [10] Biosimilars 101: considerations for US oncologists in clinical practice
    Camacho, Luis H.
    Frost, Craig P.
    Abella, Esteban
    Morrow, Phuong K.
    Whittaker, Sadie
    CANCER MEDICINE, 2014, 3 (04): : 889 - 899